Growth Metrics

Ginkgo Bioworks Holdings (DNA) Accumulated Expenses: 2020-2024

Historic Accumulated Expenses for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Dec 2024 value amounting to $65.4 million.

  • Ginkgo Bioworks Holdings' Accumulated Expenses rose 4.63% to $79.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $79.3 million, marking a year-over-year increase of 4.63%. This contributed to the annual value of $65.4 million for FY2024, which is 40.58% down from last year.
  • Per Ginkgo Bioworks Holdings' latest filing, its Accumulated Expenses stood at $65.4 million for FY2024, which was down 40.58% from $110.1 million recorded in FY2023.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Accumulated Expenses peaked at $114.7 million during FY2022, and registered a low of $30.5 million during FY2020.
  • For the 3-year period, Ginkgo Bioworks Holdings' Accumulated Expenses averaged around $96.7 million, with its median value being $110.1 million (2023).
  • Per our database at Business Quant, Ginkgo Bioworks Holdings' Accumulated Expenses spiked by 205.96% in 2021 and then slumped by 40.58% in 2024.
  • Ginkgo Bioworks Holdings' Accumulated Expenses (Yearly) stood at $30.5 million in 2020, then surged by 205.96% to $93.3 million in 2021, then grew by 22.89% to $114.7 million in 2022, then decreased by 4.05% to $110.1 million in 2023, then tumbled by 40.58% to $65.4 million in 2024.